I. Pharmacology of angiotensin antagonists.
D000081:Acetamides / Q000494:pharmacology; D000804:Angiotensin II / Q000037:antagonists & inhibitors*; D000818:Animals; D001920:Bradykinin / Q000494:pharmacology; D002087:Butyrates / Q000494:pharmacology; D006146:Guanidines / Q000494:pharmacology*; D066298:In Vitro Techniques; D007532:Isoleucine / Q000494:pharmacology; D007700:Kinetics; D007930:Leucine / Q000494:pharmacology; D008297:Male; D010879:Piperazines / Q000494:pharmacology*; D051381:Rats; D012701:Serotonin / Q000494:pharmacology; D013270:Stomach / Q000187:drug effects*; D014633:Valine / Q000494:pharmacology; D014665:Vasodilator Agents / Q000494:pharmacology*; D014992:Xylenes / Q000494:pharmacology
D000081:Acetamides; D002087:Butyrates; D006146:Guanidines; D010879:Piperazines; D014665:Vasodilator Agents; D014992:Xylenes; D007532:Isoleucine; D000804:Angiotensin II; D012701:Serotonin; D007930:Leucine; D014633:Valine; D001920:Bradykinin